Experimental Novartis radiopharma drug shows promise in early study - Reuters

Experimental Novartis radiopharma drug shows promise in early study    Reuters Novartis experimental actinium-based drug shows promise in prostate cancer treatment: Study    The Economic Times Pluvicto™ demonstrated consistent efficacy across key    GlobeNewswire Revolutionizing Prostate Cancer Treatment with Actinium-Based Drug    Devdiscourse Novartis actinium prostate cancer drug shows antitumor activity in trial    NewsBytes

Original source: Google News NA